日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effect of BZG-4000, a novel multi-targeted kinase inhibitor with potent anticancer activity, on a hepatocellular carcinoma xenograft model.

新型多靶点激酶抑制剂 BZG-4000 具有强大的抗癌活性,对肝细胞癌异种移植模型的影响

Qiu Yun-Qing, Zhou Jue, Kang Xin-Shan, Ding Lie-Ming, Yu Wei, Tan Fen-Lai, Deng Dan-Feng

Discovery of potent, orally active compounds of tyrosine kinase and serine/threonine-protein kinase inhibitor with anti-tumor activity in preclinical assays

在临床前试验中发现具有抗肿瘤活性的强效口服酪氨酸激酶和丝氨酸/苏氨酸蛋白激酶抑制剂化合物

Qiu, Yun-Qing; Zhou, Jue; Kang, Xin-Shan; Shen-Tu, Jian-Zhong; Ding, Lie-Ming; Tan, Fen-Lai; Guo, Jing; Li, Lan-Juan